Watanabe, A., Obata, T., and Nagashima, H
Retrieved June 2, 2026 via GovInfo
Of the 7,575 subjects for whom a response was received, 258 were ineligible (148 did not speak English, 92 were deceased, and 18 had moved to an aged-care facility), 3,440 refused, and 3,877 initially agreed to participate
Combining compound 968 and anti-PD-L1 antibody enhances the secretion of granzyme B from T cells and improves the antitumor activity of CD8 + T cells, prolonging the overall survival of ovarian cancer mice
The compound has been shown in cell-based research to upregulate VEGFR2 transcript levels, increase phosphorylation of downstream signalling intermediates after VEGF stimulation, and enhance endothelial tube formation in matrigel assays
The headline number, though, is the same across the board: eligible beneficiaries pay a $50 copay for a 30-day supply, compared with the roughly $1,000-plus these drugs can cost at list price